Bain Capital-backed Emcure Pharmaceuticals is set to launch its Initial Public Offering (IPO) on July 3, 2024. The company has established a price band of Rs 960-1008 per share and aims to raise up to Rs 1,952 crore through the issuance of 7.9 million equity shares. The IPO size is Rs 1,952 crore. The IPO will help fund Emcure's growth plans, debt reduction, and revenue boost strategies. Insights from key executives, including Satish Mehta and Namita Thapar, will be featured on ET NOW. The IPO will hit Dalal Street on July 3.
#OnETNOW | Emcure Pharma's IPO opens next week! What are their plans for growth, debt reduction, and revenue boost? Catch Satish Mehta and Namita Thapar's insights on ET NOW! @EmcurePharma @namitathapar @SnehiShah11 @_sherylld https://t.co/8YmJHPg7ZX
Emcure Pharmaceuticals has set a price band of Rs 960-1008 per share for its IPO that opens for subscription on July 3, seeking to raise up to Rs 1952 crore through a fresh issue of 7.9 million equity shares. @sohinidastweets #EmcurePharma #IPO https://t.co/Or2zGZyQiK
Namita Thapar's @EmcurePharma #IPO to hit Dalal Street on July 3: Check price band, other details https://t.co/H77Z2ke5HM
IPO Alert | Emcure IPO price band of Rs 960-1008/sh; IPO size at Rs 1,952 cr @EmcurePharma https://t.co/rZP77vjPsi
Bain Capital-backed Emcure Pharma To Float IPO On July 3, Check Issue Size and Other Details #emcure #Pharmaceutical #IPO https://t.co/HPnBGv8Mts